How Will the Market React to Cassava Sciences Inc (SAVA) Stock Getting a Bullish Rating

Overall market sentiment has been high on Cassava Sciences Inc (SAVA) stock lately. SAVA receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Cassava Sciences Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SAVA!

See Full SAVA Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With SAVA Stock Today?

Cassava Sciences Inc (SAVA) stock is down -4.65% while the S&P 500 has risen 0.16% as of 11:23 AM on Monday, Nov 6. SAVA is lower by -$1.06 from the previous closing price of $22.70 on volume of 704,037 shares. Over the past year the S&P 500 has risen 14.67% while SAVA is lower by -36.53%. SAVA lost -$2.19 per share in the over the last 12 months.

More About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. Click Here to get the full Stock Report for Cassava Sciences Inc stock.